Charles Rhyee
Stock Analyst at TD Cowen
(4.15)
# 1,558
Out of 4,596 analysts
658
Total ratings
52.2%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintained: Hold | $23 | $23.03 | -0.13% | 7 | Aug 2, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $197 | $163.57 | +20.44% | 21 | Aug 2, 2026 | |
| IQV IQVIA Holdings | Rated: Buy | $213 → $288 | $235.02 | +22.54% | 25 | Jul 29, 2026 | |
| EVH Evolent Health | Maintained: Buy | $8 → $5 | $3.09 | +61.81% | 49 | Jul 28, 2026 | |
| MEDP Medpace Holdings | Rated: Hold | $419 → $492 | $577.11 | -14.75% | 15 | Jul 23, 2026 | |
| MCK McKesson | Maintained: Buy | $1,012 → $989 | $856.19 | +15.51% | 50 | Jul 21, 2026 | |
| CAH Cardinal Health | Maintained: Buy | $255 → $275 | $230.03 | +19.55% | 39 | Jul 9, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $65 → $81 | $59.71 | +35.66% | 11 | Jun 18, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $235 | $232.51 | +1.07% | 22 | Jun 4, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $300 → $235 | $203.78 | +15.32% | 20 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $400 | $311.34 | +28.48% | 50 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.80 | +66.67% | 21 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $7.27 | +51.31% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $110 | $104.43 | +5.33% | 58 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 → $4 | $3.07 | +30.29% | 36 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $39.28 | +34.93% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $8 | $10.75 | -25.58% | 20 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $18 | $19.17 | -6.10% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $338 | $279.05 | +21.13% | 17 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 | $6.71 | -10.58% | 58 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $21.11 | +98.96% | 9 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $9 | $5.22 | +72.41% | 19 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.14 | +191.83% | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $28.38 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $84.90 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.21 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $196.83 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $1.3 | $0.000001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $415 | $414.40 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $360 → $395 | $375.84 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $31.22 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $80 | $62.22 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $410 → $460 | $363.86 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $195.62 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $29 | $35.37 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $23.22 | n/a | 1 | Feb 25, 2014 |
Option Care Health
Aug 2, 2026
Maintained: Hold
Price Target: $23
Current: $23.03
Upside: -0.13%
ICON Public Limited Company
Aug 2, 2026
Maintained: Buy
Price Target: $197
Current: $163.57
Upside: +20.44%
IQVIA Holdings
Jul 29, 2026
Rated: Buy
Price Target: $213 → $288
Current: $235.02
Upside: +22.54%
Evolent Health
Jul 28, 2026
Maintained: Buy
Price Target: $8 → $5
Current: $3.09
Upside: +61.81%
Medpace Holdings
Jul 23, 2026
Rated: Hold
Price Target: $419 → $492
Current: $577.11
Upside: -14.75%
McKesson
Jul 21, 2026
Maintained: Buy
Price Target: $1,012 → $989
Current: $856.19
Upside: +15.51%
Cardinal Health
Jul 9, 2026
Maintained: Buy
Price Target: $255 → $275
Current: $230.03
Upside: +19.55%
BrightSpring Health Services
Jun 18, 2026
Rated: Buy
Price Target: $65 → $81
Current: $59.71
Upside: +35.66%
Charles River Laboratories International
Jun 4, 2026
Reiterated: Buy
Price Target: $235
Current: $232.51
Upside: +1.07%
Veeva Systems
Jun 4, 2026
Maintained: Buy
Price Target: $300 → $235
Current: $203.78
Upside: +15.32%
Jun 1, 2026
Rated: Buy
Price Target: $400
Current: $311.34
Upside: +28.48%
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $4.80
Upside: +66.67%
May 13, 2026
Maintained: Hold
Price Target: $11
Current: $7.27
Upside: +51.31%
May 11, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $104.43
Upside: +5.33%
May 11, 2026
Rated: Buy
Price Target: $3 → $4
Current: $3.07
Upside: +30.29%
May 7, 2026
Maintained: Buy
Price Target: $53
Current: $39.28
Upside: +34.93%
May 6, 2026
Rated: Hold
Price Target: $5 → $8
Current: $10.75
Upside: -25.58%
May 5, 2026
Rated: Buy
Price Target: $15 → $18
Current: $19.17
Upside: -6.10%
May 4, 2026
Rated: Buy
Price Target: $338
Current: $279.05
Upside: +21.13%
May 4, 2026
Rated: Hold
Price Target: $6
Current: $6.71
Upside: -10.58%
May 4, 2026
Reiterated: Buy
Price Target: $42
Current: $21.11
Upside: +98.96%
Feb 20, 2026
Maintained: Buy
Price Target: $6 → $9
Current: $5.22
Upside: +72.41%
Nov 13, 2025
Maintained: Buy
Price Target: $15
Current: $5.14
Upside: +191.83%
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $28.38
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $84.90
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $20.21
Upside: n/a
Oct 30, 2023
Maintained: Buy
Price Target: $170
Current: $196.83
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2022
Maintained: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Maintained: Sell
Price Target: $9 → $1.3
Current: $0.000001
Upside: n/a
Apr 16, 2021
Maintained: Buy
Price Target: $370 → $415
Current: $414.40
Upside: n/a
Apr 14, 2021
Maintained: Buy
Price Target: $360 → $395
Current: $375.84
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $31.22
Upside: n/a
Feb 8, 2021
Maintained: Buy
Price Target: $74 → $80
Current: $62.22
Upside: n/a
Feb 1, 2021
Maintained: Hold
Price Target: $410 → $460
Current: $363.86
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $195.62
Upside: n/a
Oct 30, 2015
Maintained: Hold
Price Target: $30 → $29
Current: $35.37
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $23.22
Upside: n/a